Last stop before meeting all my friends in #PSOGI23 Olivia Sgarbura Blanca Valenzuela Méndez Santiago González-Moreno

PSOGI Congress is beginning!!! Peritoneal Surface Oncology Group International Paul H Sugarbaker SoMe4Peritoneum #peritonealsurfaceoncology

Summary of the nourishing start of the Peritoneal Surface Oncology Group International 2023 Venezia conference : “Consensus on #hipec regimens for different PSM” great common effort @RENAPE_Network Martin Hübner glen Kurt Van der Speeten Aditi Bhatt clarisse Asociación Peritoneum Vahan Képénékian Olivia Sgarbura

Directly from Chile to Venice to participate in PSOGI 2023, with plans to boost Peritoneal Surface Oncology in their country… and the creation of a Chilean Society of Surgical Oncology. Congratulations!

Learning lessons from Peritoneal Surface Oncology history makers at PSOGI 2023

Awesome 👏🏅🏆👏👏👏👏👏⭐️⭐️⭐️⭐️⭐️THE PSOGI INTERVIEW: Interviewers: D. Morris&B. Moran LEGEND P. H. Sugarbaker (Washington) "Peritoneal Surface Malignancies: We have come a long way; we have a long way to go"Peritoneal Surface Oncology Group International Indian society of peritoneal surface malignancy ISSPP Paul H Sugarbaker

Peritoneal Surface Oncology Group International consensus use of HIPEC in peritoneal metastatic Gastric Cancer, more questions than answers… and what are we doing in latinamerican patients? We need to work #PSOGI2023 #SurgicalOncology

Update on Cairo 6 Ignace de Hingh Recruitment is nearly complete 20 patients to go.. We already have phase 2 published in JAMA Surgery #Barcelona2025 perhaps- results of Phase 3 Thales P. Batista, MD, PhD Peter Cashin Alvaro Arjona Andreas Brandl Faraz Khan Delia Cortés Guiral Olivia Sgarbura

Prof van Driel brilliantly presented practice-changing data out of the OVHIPEC-1 trial in PSOGI 2023. Patients with stage III ovarian cancer following neoadjuvant systemic chemotherapy and interval complete cytoreduction benefit from adding HIPEC with Cisplatin.Peritoneal Surface Oncology Group International

Surgical Oncology in general, and Peritoneal Surface Oncology in particular, is learnt through mentorship. Thank you Paul for still serving as my mentor 23 years later, and for having taught me how to be a good one.

Thank you very much Santiago González-Moreno for all the Mentoring through this years, now I conclude this training journey to bring back to Chile all learned experiencies. Glad to been able to have such a great team in ICM thanks Olivia Sgarbura and FrançoisQuenet

Approximately 25% of cancer survivors have persistent problems, including anxiety and depression. In recognition of World Mental Health Day, hear from Dr. Patricia Ganz of @uclajccc on psychosocial distress in survivors. spr.ly/6017uO8JD

#PERITONEALMESOTHELIOMA NCCN guidelines, 2023 update doi.org/10.6004/jnccn.… 🌟CRS +HIPEC remains the std of care for medically operable & completely resectable dz🌟 Heartening to see these 2 imp prognostic factors on the NCCN gls (image 2) Major updates: Terminology-

Before you tweet, T-H-I-N-K-- T: Is it true? H: Is it helpful? I: Is it inspiring? N: Is it necessary? K: Is it kind?

CAR-T cells for treating peritoneal carcinomatosis is not restricted only to colorectal cancer. Siyuan Qian explains its efficacy in PC from pancreatic cancer. pedro villarejo campos Víctor Domínguez Damian Garcia-Olmo, Professor of Surgery HBP & UpGI Surgery Hector Guadalajara Montiel Jiménez, MD., PhD., FEBS EmSurg, FEBS HPB Pedro Cascales

Ayer me robaron el teléfono Carabineros de Chile, hoy desperté con la ubicación. Será posible rescatarlo??

🚨Video del abordaje de la zona 2 para las metástasis peritoneales, presentado por la Dra. Marina Bosch, Lana Bijelic Domenico Sabia Julián Henao Ardila Consorci Sanitari Integral GECOP GECOP SEOQ | Los cirujanos del cáncer #operarelcancer Societat Catalana de Cirurgia European Society of Surgical Oncology (ESSO) #carcinomatosis AEC Formación

El webinar mensual del Capítulo Español del American College of Surgeons tendrá lugar el próximo Miércoles 6 de Marzo, 7 pm. La Dra. Lana Bijelic y yo ofreceremos una visión global sobre Oncología Peritoneal, así como retos presentes y futuros en investigación clínica. ¡Estás invitados!

Cutting edge peritoneal surface oncology in the southern country of the world SoMe4Peritoneum Peritoneal Surface Oncology Group International Paul H Sugarbaker #CHILE #HIPEC